Roche Reports Positive Results From Head-to-Head Study on NSCLC Drug
Roche RHHBY reported positive results from the late-stage Krascendo 1 study evaluating experimental candidate, divarasib, in patients with…
Roche KRAS drug succeeds in head-to-head lung cancer study
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free…